Advances in Small-Cell Lung Cancer (SCLC) Translational Research.

Cold Spring Harbor Perspectives in Medicine
Benjamin J Drapkin, Charles M Rudin

Abstract

Over the past several years, we have witnessed a resurgence of interest in the biology and therapeutic vulnerabilities of small-cell lung cancer (SCLC). This has been driven in part through the development of a more extensive array of representative models of disease, including a diverse variety of genetically engineered mouse models and human tumor xenografts. Herein, we review recent progress in SCLC model development, and consider some of the particularly active avenues of translational research in SCLC, including interrogation of intratumoral heterogeneity, insights into the cell of origin and oncogenic drivers, mechanisms of chemoresistance, and new therapeutic opportunities including biomarker-directed targeted therapies and immunotherapies. Whereas SCLC remains a highly lethal disease, these new avenues of translational research, bringing together mechanism-based preclinical and clinical research, offer new hope for patients with SCLC.

References

Sep 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·G M ElringtonJ Newsom-Davis
Feb 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·M M NauJ D Minna
Nov 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J R JettJ B Gerstner
Dec 1, 1993·Genes & Development·D CobrinikR A Weinberg
Dec 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K KellyS Rivkin
Oct 1, 1995·Current Opinion in Immunology·J P AllisonD R Leach
Mar 22, 1996·Science·D R LeachJ P Allison
Jan 1, 1996·Journal of Cellular Biochemistry. Supplement·B E JohnsonA F Gazdar
Feb 21, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·N van ZandwijkG Giaccone
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·P A Bretscher
Sep 17, 1999·The American Journal of Pathology·A J ManiotisM J Hendrix
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P ChuteB E Johnson
Jun 6, 2000·Developmental Biology·A Meredith, J E Johnson
Feb 27, 2001·Nature Immunology·Y LatchmanG J Freeman
Apr 3, 2001·The Journal of Experimental Medicine·S Y TsengH Tsuchiya
Feb 15, 2002·The Journal of Biological Chemistry·Thorsten StieweBrigitte M Pützer
Apr 10, 2002·Molecular and Cellular Biology·Virote SriuranpongDouglas W Ball
Sep 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Yoshiko IwaiNagahiro Minato
Jun 5, 2003·Nature Reviews. Cancer·Mary J C HendrixRichard E B Seftor
Oct 29, 2004·Nature Reviews. Cancer·Nicholas TurnerAlan Ashworth

❮ Previous
Next ❯

Citations

Jan 16, 2021·Nature Reviews. Disease Primers·Charles M RudinJulien Sage
Mar 16, 2021·Molecular Therapy Oncolytics·Anna SchwendenweinBalazs Dome

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Chest Surgery Clinics of North America
C L Williams
Zhongguo fei ai za zhi = Chinese journal of lung cancer
Shuang ZhangYing Cheng
© 2022 Meta ULC. All rights reserved